JPWO2020227097A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020227097A5
JPWO2020227097A5 JP2021564996A JP2021564996A JPWO2020227097A5 JP WO2020227097 A5 JPWO2020227097 A5 JP WO2020227097A5 JP 2021564996 A JP2021564996 A JP 2021564996A JP 2021564996 A JP2021564996 A JP 2021564996A JP WO2020227097 A5 JPWO2020227097 A5 JP WO2020227097A5
Authority
JP
Japan
Prior art keywords
alkyl
epilepsy
group
formula
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021564996A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022530989A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/031039 external-priority patent/WO2020227097A1/en
Publication of JP2022530989A publication Critical patent/JP2022530989A/ja
Publication of JPWO2020227097A5 publication Critical patent/JPWO2020227097A5/ja
Pending legal-status Critical Current

Links

JP2021564996A 2019-05-03 2020-05-01 Kcnt1阻害剤および使用する方法 Pending JP2022530989A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962842855P 2019-05-03 2019-05-03
US201962842861P 2019-05-03 2019-05-03
US201962842858P 2019-05-03 2019-05-03
US62/842,861 2019-05-03
US62/842,858 2019-05-03
US62/842,855 2019-05-03
US202062982858P 2020-02-28 2020-02-28
US62/982,858 2020-02-28
PCT/US2020/031039 WO2020227097A1 (en) 2019-05-03 2020-05-01 Kcnt1 inhibitors and methods of use

Publications (2)

Publication Number Publication Date
JP2022530989A JP2022530989A (ja) 2022-07-05
JPWO2020227097A5 true JPWO2020227097A5 (es) 2023-05-11

Family

ID=73050875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021564996A Pending JP2022530989A (ja) 2019-05-03 2020-05-01 Kcnt1阻害剤および使用する方法

Country Status (16)

Country Link
US (1) US20220280476A1 (es)
EP (1) EP3962479A4 (es)
JP (1) JP2022530989A (es)
KR (1) KR20220016469A (es)
CN (1) CN114206335A (es)
AU (1) AU2020267355A1 (es)
BR (1) BR112021022061A2 (es)
CA (1) CA3139062A1 (es)
CL (1) CL2021002876A1 (es)
CO (1) CO2021016469A2 (es)
EC (1) ECSP21087657A (es)
IL (1) IL287751A (es)
MX (1) MX2021013422A (es)
PE (1) PE20220017A1 (es)
SG (1) SG11202112212WA (es)
WO (1) WO2020227097A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7066871B2 (ja) 2017-12-15 2022-05-13 シロニックス リニューアブルス,インコーポレイティド 界面活性剤を形成するための反応性蒸留
WO2020014304A1 (en) 2018-07-12 2020-01-16 Sironix Renewables, Llc Surfactants from long-chain carbon-containing molecules
KR20220016469A (ko) * 2019-05-03 2022-02-09 프락시스 프리시젼 메디신즈, 인크. Kcnt1 억제제 및 사용 방법
WO2021225932A1 (en) * 2020-05-04 2021-11-11 Sironix Renewables, Inc. Furan surfactant compositions and methods
US11773088B2 (en) 2020-11-02 2023-10-03 Praxis Precision Medicines, Inc. KCNT1 inhibitors and methods of use
EP4267133A2 (en) * 2020-12-22 2023-11-01 Praxis Precision Medicines, Inc. Kcnt1 inhibitors and methods of use
WO2022231872A1 (en) * 2021-04-29 2022-11-03 Praxis Precision Medicines, Inc. Kcnt1 inhibitors and methods of use
WO2023211855A1 (en) * 2022-04-25 2023-11-02 Praxis Precision Medicines, Inc. Kcnt1 inhibitors comprising a thiophene core and methods of use
WO2024123717A1 (en) * 2022-12-05 2024-06-13 Praxis Precision Medicines, Inc. Kcnt1 inhibitors comprising a phenyl, pyridine, or pyrimidine core and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19929076A1 (de) * 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
AU5464901A (en) * 2000-03-01 2001-09-12 Nihon Bayer Agrochem K.K. Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
TWI243164B (en) * 2001-02-13 2005-11-11 Aventis Pharma Gmbh Acylated indanyl amines and their use as pharmaceuticals
WO2005066137A1 (en) * 2003-12-19 2005-07-21 Neurogen Corporation 2,5-diaryl-1h-imidazole-4-carboxamides as neurokinin-3 receptor modulators for the treatment of central nervous system and peripheral diseases
KR20070092297A (ko) * 2004-12-21 2007-09-12 데브젠 엔브이 Kv4 이온 채널 활성을 갖는 화합물
EP3638790A4 (en) * 2017-06-13 2021-03-10 The Florey Institute Of Neuroscience And Mental Health COMPOSITIONS AND METHODS FOR DEALING WITH CONDITIONS ASSOCIATED WITH FUNCTION GAIN MUTATIONS IN KCNT1
MA51620A (fr) * 2018-01-19 2020-11-25 Cytokinetics Inc Analogues de dihydrobenzofurane et d'inden en tant qu'inhibiteurs de sarcomes cardiaques
CN108517358A (zh) * 2018-04-09 2018-09-11 重庆医科大学附属第医院 一种辅助癫痫诊断的标志物及其检测试剂盒
KR20220016469A (ko) * 2019-05-03 2022-02-09 프락시스 프리시젼 메디신즈, 인크. Kcnt1 억제제 및 사용 방법

Similar Documents

Publication Publication Date Title
JP5733982B2 (ja) サイトカインの産生を抑制する化合物及びその調製方法
KR100806978B1 (ko) 1,5-이치환된-3,4-디히드로-1h-피리미도[4,5-d]피리미딘-2-온 화합물 및 csbp/p38 키나제 매개된 질환의치료시 이들의 용도
AU726084C (en) Novel substituted imidazole compounds
JPWO2020227097A5 (es)
PT1864975E (pt) Derivados de nicotinamida úteis como inibidores de p38
US8648084B2 (en) Selective substituted pyrazine ligands for neuronal nicotinic receptors
AU2003303484B2 (en) Quinazolinones as potassium channel modulators
EP3356334B1 (de) Acylierte n-(1,2,5-oxadiazol-3-yl)-, n-(1,3,4-oxadiazol-2-yl)-, n-(tetrazol-5-yl)- und n-(triazol-5-yl)-arylcarbonsäureamide und ihre verwendung als herbizide
JP2006513268A5 (ja) アンタゴニスト活性を有するベンゾアゾリルピペラジン誘導体
JP2006506462A5 (es)
JPS637545B2 (es)
JP2008513413A5 (es)
JP2006502143A5 (es)
RU2009147708A (ru) Производные оксадиазола и их применение в качестве потенцирующих средств метаботропных глутаматных рецепторов-842
CA2378241A1 (en) Benzanilides as potassium channel openers
JP2003506387A5 (es)
JPH11507358A (ja) Ctfレセプターアンタゴニストとして有用なアミノ置換チアジアゾール、ピリミジン、トリアジン、またはトリアゾール
WO1997025045A1 (en) Novel substituted imidazole compounds
AU2242597A (en) Novel cycloalkyl substituted imidazoles
EP1264827A1 (en) Process for the preparation of Tosylbenzylformamides
JP2005047930A5 (es)
EP3478679B1 (en) 5,7-dihydro-pyrrolo-pyridine derivatives for treating neurological and neurodegenerative diseases
JP2008542365A5 (es)
EP2070924A1 (de) Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel
JPH0649688B2 (ja) ピリミジン誘導体、その製造法およびその医薬組成物